Medical Professionals and Patients

It is said that drugs cannot fulfill their proper roles unless they are used together with the appropriate information.
Bearing this in mind, we are quick to provide medical institutions with accurate information about the proper use of our drugs. We do this through our medical representatives (MRs), who are located nationwide. At the same time, we work to collect information on quality and safety, consolidate collected safety particulars, and provide this to assist in creating new pharmaceutical preparations.

1. Initiatives to Ensure Proper Use of Drugs

We train our MRs to provide information and we teach them about the proper use and efficacy of our products. With the patient always in mind, we strive to cultivate human resources who can serve as members of team-based healthcare for pharmacotherapy partners.
A variety of information is available on our website. Information targeting medical professionals includes news about National Health Insurance price revisions, and guidance on administering drugs. We also supply information about generics, and provide recipes for therapeutic food and other information for patients.We make available various leaflets about new drugs and generics, providing information to meet medical institutions’ needs. Further, we provide separate websites for medical professionals and patients concerning hyperuricemia and gout. The data is tailored to groups’ different needs and levels of knowledge.

(1) Role of MRs
Nationwide, we have approximately 250 MRs, whose function is to provide information on the use of drugs, instructions for patients, and to meet other needs of medical institutions.
We continue working to ensure the efficiency of our MRs’ activities by maintaining ties with individual medical institutions, particularly core hospitals that are central to regional healthcare.

(2) Platform for Learning
The Company conducts seminars and has study groups for various medical conditions, including dementia and lifestylerelated illnesses, providing medical professionals with the most up-to-date information and serving as a venue for exchanges of opinion related to treatment.
Since 2005, we have supported the operation of the DPC Management Forum to discuss the combined diagnosis procedures the Japanese government is promoting.

(3) Oncology Market
With the number of oncology patients growing as the population ages, demand is increasing for generic anti-cancer agents. In 2013, we set up an oncology promotion section to enable MRs to provide cancer-related information. We also started to conduct seminars for healthcare professionals on oncology drug therapies.

(4) Support Materials
For physicians and pharmacists we publish a periodical by means of which we share our latest information. We also produce pamphlets that provide guidance on various types of nutrition-related and exercise therapies, as well as on health management.
Through these supporting materials, we are doing our best to help improve the quality of healthcare.

(5) Response to Inquiries Swift
To ensure accurate and speedy responses to telephone inquiries from medical professionals and patients, we have established a customer support office to help provide information on the appropriate use of our pharmaceuticals.

2. Strengthening Supply System

To provide a stable supply of medications—as called for in the “Roadmap for further promotion of the use of generic medicines,” formulated by the Ministry of Health, Labour and Welfare—we are diversifying our active pharmaceutical ingredient procurement partners, and stepping up inspections of local manufacturing facilities.
Further support for stable supplies comes from a Group company’s Tsukuba Factory, which has the industry’s first fully seismically isolated structure in this earthquake-prone nation. In addition, we have built a factory in Vietnam and, still focusing on attaining stable supplies, we continue to make improvements throughout the supply chain, from development and manufacturing to sales. We have also established a supply system through pharmaceutical wholesaling.

3. Quality, Information Paramount

We are working on initiatives to ensure the quality of both generics and proprietary products, as well as to provide information more effectively. At the same time, we are devising ways to improve the visibility and user-friendliness of our products.
When packaging our products, we take ample care to ensure the safety and security of medical professionals and patients alike. Examples of such activities include using press-through packaging sheets for oral medications and employing external packaging to prevent exposure to anticancer medications.

Product Initiatives Aimed at Safety and Convenience

1. Matte press-through packaging
Reduced shine makes it easier to read the information and instructions written on the aluminum backing of medication packaging.
2. Universal design font
For sheets of press-through packaging and outer packaging, we use a font that is highly legible, to prevent misreading.


3.Tablet imprint
All tablets have the name of the drug and the maker printed, on the top
and bottom half, respectively, on one side, and the bottom and top half on
the other side. Tablets are scored on both sides.


4.Designed to reduce exposure
After filling a vial with medication, any remaining anti-cancer agent is cleaned away from the outer surface of the vial, which is then wrapped in film.
5.Prevents bottles breaking, contents scattering
Cushioning material is placed at the bottom of the vial before it is covered in shrink-wrap film.

Related Information